CSL Appoints New Directors
Dr Brian McNamee AO and Mr Abbas Hussain have been appointed as independent Non-Executive Directors, effective 14 February 2018.
New National Fractionation Agreement
CSL Behring today announced that it has signed an agreement with the National Blood A…
Expansion of CSL Biotech Facility
CSL today officially opened a new AUD$230 million advanced manufacturing facility at …
CSL and Vitaeris Strategic Partnership
Agreement to expedite the development of clazakizumab (an anti-IL6 MAB, formerly ALD5…
CSL112 Phase 3 Clinical Trial
The study will be the largest ever undertaken by CSL, and will enroll more than 17,00…
We are passionate about people
Senior Vice President and General Manager, CSL Plasma
When Mike Deem joined CSL nearly 30 years ago, he was a college student in search of tuition reimbursement. That college job turned into an exciting career. He's now SVP and General Manager of CSL Plasma and credits his success to the mentors and development opportunities provided by the company.